Quantum-Si (NASDAQ:QSI - Get Free Report) is projected to issue its quarterly earnings data after the market closes on Monday, March 3rd. Analysts expect the company to announce earnings of ($0.18) per share and revenue of $1.23 million for the quarter. Persons interested in registering for the company's earnings conference call can do so using this link.
Shares of QSI stock opened at $1.38 on Friday. The stock's 50 day simple moving average is $2.23 and its 200 day simple moving average is $1.43. Quantum-Si has a twelve month low of $0.61 and a twelve month high of $5.77. The company has a market capitalization of $196.94 million, a price-to-earnings ratio of -2.16 and a beta of 2.70.
In other Quantum-Si news, Director Jonathan M. Rothberg sold 3,506,267 shares of the stock in a transaction on Friday, December 27th. The shares were sold at an average price of $3.34, for a total value of $11,710,931.78. Following the completion of the sale, the director now directly owns 1,250,000 shares of the company's stock, valued at $4,175,000. This represents a 73.72 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 30.04% of the company's stock.
A number of research firms have recently commented on QSI. HC Wainwright reissued a "buy" rating and issued a $5.50 price target on shares of Quantum-Si in a research report on Tuesday, January 14th. Alliance Global Partners started coverage on shares of Quantum-Si in a report on Friday, February 7th. They issued a "buy" rating and a $3.75 target price on the stock. Finally, Canaccord Genuity Group decreased their price target on shares of Quantum-Si from $1.50 to $1.00 and set a "hold" rating for the company in a report on Wednesday, November 13th.
Get Our Latest Stock Report on Quantum-Si
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Quantum-Si, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Quantum-Si wasn't on the list.
While Quantum-Si currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.